title: Combined modality adjuvant treatment of high-risk rectal cancer: a treatment of choice or a choice of treatment?
authors.affiliation: Laurentius Hospital, Roermond, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Wils
authors.forename: D J
authors.initials: DJ
authors.lastname: Wagener
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D012673:Semustine / Q000008:administration & dosage
chemical_list: D012673:Semustine; D007978:Levamisole; D005472:Fluorouracil